Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Sherbrooke

$17,500.00

Applying pepducin technology to the treatment of chronic pain

FY 2015-16

Summary
The treatment of chronic pain is an incredibly important medical issue. Nearly 20% of adults suffer from chronic pain on a daily basis, and unfortunately, most of the treatments available are not effective. Our team is now working on a new, promising strategy in pain relief called pepducins. Pepducins are small, cell-penetrating proteins that are designed to mimic and interact with receptors in a unique way. Rather than simply fitting into a receptor, like a key into a lock, they imbed themselves in the cell membrane, flip towards the inside of the cell, and interact with the receptor there, modifying the signals that it is sending. Although pepducins have been developed to tackle different diseases, they have not yet been studied in the context of pain. This is precisely our aim, and so, our team has designed pepducins targeting two different receptors involved in pain transmission. Our goal is therefore to study pepducin behavior both on cells and on live animals (rats). This will involve testing for analgesia (pain-relief) in acute pain models, but also in tonic andchronic pain models. All in all, this research is extremely valuable, as it may lead to new and much-needed pain-relievers.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
350190
Name
Brouillette Rebecca
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Applying pepducin technology to the treatment of chronic pain
Programtype2
Studentship Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biased Signaling; Bret; Ccr2; Chronic Pain; G Protein Coupled Receptor (Gpcr); Nts1; Pepducins
Abstract
The treatment of chronic pain is an incredibly important medical issue. Nearly 20% of adults suffer from chronic pain on a daily basis, and unfortunately, most of the treatments available are not effective. Our team is now working on a new, promising strategy in pain relief called pepducins. Pepducins are small, cell-penetrating proteins that are designed to mimic and interact with receptors in a unique way. Rather than simply fitting into a receptor, like a key into a lock, they imbed themselves in the cell membrane, flip towards the inside of the cell, and interact with the receptor there, modifying the signals that it is sending. Although pepducins have been developed to tackle different diseases, they have not yet been studied in the context of pain. This is precisely our aim, and so, our team has designed pepducins targeting two different receptors involved in pain transmission. Our goal is therefore to study pepducin behavior both on cells and on live animals (rats). This will involve testing for analgesia (pain-relief) in acute pain models, but also in tonic andchronic pain models. All in all, this research is extremely valuable, as it may lead to new and much-needed pain-relievers.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brouillette, Rebecca
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
Université de Sherbrooke - $17,500 Grant (2015-16) | Canada Spends